Incidence and Characteristics of Atypical Femoral Fractures: Clinical and Geometrical Data

Cortical Thickness of the Femur and Long-Term Bisphosphonate Use

(2015) Rui Niimi et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Absence of femoral cortical thickening in long-term bisphosphonate users: Implications for atypical femur fractures

(2014) Foster Chen et al.   BONE

Symptomatic atypical femoral fractures are related to underlying hip geometry

(2014) David P. Taormina et al.   BONE

The Correlation Between Lateral Bowing Angle of the Femur and the Location of Atypical Femur Fractures

(2014) Lei-Po Chen et al.   CALCIFIED TISSUE INTERNATIONAL

Association of Atypical Femoral Fractures with Bisphosphonate Use by Patients with Varus Hip Geometry

(2014) Jennifer E Hagen et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Prodromal Symptoms in Patients with Bisphosphonate-Associated Atypical Fractures of the Femur

(2014) Mohammad Kharazmi et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series

(2014) Yoto Oh et al.   JOURNAL OF ORTHOPAEDIC SCIENCE

Risk of Atypical Femoral Fracture during and after Bisphosphonate Use

(2014) Jörg Schilcher et al.   NEW ENGLAND JOURNAL OF MEDICINE

The clinical characteristics of patients with hip fractures in typical locations and atypical femoral fractures

(2014) Soledad Velasco et al.   Archives of Osteoporosis

Statin Use and Fracture Risk

(2013) Lawrence C. McCandless   EPIDEMIOLOGY

Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis

(2013) Lydia Gedmintas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

(2013) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical femoral fractures and bisphosphonate treatment

(2012) R. N. Thompson et al.   JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME

Incidence of atypical nontraumatic diaphyseal fractures of the femur

(2012) Richard M Dell et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical fractures do not have a thicker cortex

(2012) V. A. Koeppen et al.   OSTEOPOROSIS INTERNATIONAL

The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study

(2012) L-A. Fraser et al.   OSTEOPOROSIS INTERNATIONAL

Atypical fractures and bisphosphonate therapy: A cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features

(2011) Andrea Giusti et al.   BONE

The Effect of Long-term Alendronate Treatment on Cortical Thickness of the Proximal Femur

(2011) Aasis Unnanuntana et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

(2011) Laura Y. Park-Wyllie   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bisphosphonate Use and Atypical Fractures of the Femoral Shaft

(2011) Jörg Schilcher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atypical fractures of the femur and bisphosphonate therapy

(2010) Andrea Giusti et al.   BONE

A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover

(2010) Andrew J Burghardt et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

(2010) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonates for Osteoporosis

(2010) Murray J. Favus   NEW ENGLAND JOURNAL OF MEDICINE

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene

(2010) P. Vestergaard et al.   OSTEOPOROSIS INTERNATIONAL

Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate

(2009) Jörg Schilcher et al.   Acta Orthopaedica

Unusual mid-shaft fractures during long-term bisphosphonate therapy

(2009) Clarita V. Odvina et al.   CLINICAL ENDOCRINOLOGY

Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates

(2009) Kuntheavy Ing-Lorenzini et al.   DRUG SAFETY

Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium

(2009) Joon Kiong LEE   International Journal of Rheumatic Diseases

Bilateral Fractures of the Femur Diaphysis in a Patient With Rheumatoid Arthritis on Long-Term Treatment With Alendronate: Clues to the Mechanism of Increased Bone Fragility

(2009) Matthijs P Somford et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Subtrochanteric displaced insufficiency fracture after long‐term alendronate therapy—a case report

(2008) Arkan S Sayed-Noor et al.   Acta Orthopaedica

Severely Suppressed Bone Turnover and Atypical Skeletal Fragility

(2008) Maja Visekruna et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

(2008) B. A. Lenart et al.   OSTEOPOROSIS INTERNATIONAL